Lifeward Ltd. (LFWD): Insider Trading, Congress Trades & Research | Tormere

LFWD

$5.83-3.80%visit website

Lifeward Ltd.

Market Cap

$17M

Live price × SEC shares (Aug 12, 2026)

Sector

Health Care

Industry

Health Care

Beta (raw)

0.56

60mo monthly vs SPY

P/E (TTM)

N/M

TTM to Jun 2026 · negative earnings

P/S (TTM)

0.8

TTM to Jun 2026 · revenue

P/B

1.4

Mkt cap / shareholders' equity

EV/EBITDA (TTM)

—

EV / TTM EBITDA

Loading…

Financial Statements

USD thousands	Q3 FY2025 Sep 30, 2025	Q4 FY2025 Dec 31, 2025	Q1 FY2026 Mar 31, 2026	Q2 FY2026 Jun 30, 2026	TTM Jun 30, 2026
Revenue	6,195	5,081	3,923	6,623	21,822
Cost of revenue	3,488	3,993	2,581	3,914	13,976
Gross profit	2,707	1,088	1,342	2,709	7,846
Research & development	721	843	5,845	1,754	9,163
Total operating expenses	5,847	6,206	11,681	6,861	30,595
Operating income	(3,140)	(5,118)	(10,339)	(4,152)	(22,749)
Interest expense			416	7,074
Pretax income	(3,163)	(5,421)	(10,787)	(11,509)	(30,880)
Income tax	7.0	(73.0)	6.0	10.0	(50.0)
Net income	(3,170)	(5,348)	(10,793)	(11,519)	(30,830)
EPS (basic) ($)	(0.20)		(6.70)	(4.12)	—
EPS (diluted) ($)	(0.20)		(6.70)	(4.12)	—
Weighted avg. shares (basic)	16,021		1,611	2,797
Weighted avg. shares (diluted)	16,021		1,611	2,797

Source: SEC XBRL filings (10-K, 10-Q). Per-share data in dollars; shares in thousands. Latest: 10-Q filed Aug 14, 2026, period ended Jun 30, 2026. flagged for review— withheld, failed a consistency check restated or split-adjustedhover a value for its source

Showing the last 5 quarters. 42 more quarters, back to Mar 2015, with Tormere Pro.

Signals

Insider Velocity

no recent activity

purchases / sales, 90d

Market & Alt Data

News

15

recent articles

Lifeward Ltd. · 2026-05-14

Analyst Consensus

Strong Buy

8 analysts

Sort by

Type

Trade Date	Filed	Owner	Role	Type	Shares	Price	Value	Owned After
2025-05-21	2025-05-22	Jasinski Lawrence J	Director & Chief Executive Officer	Sale	1,909	$1.26	$2K	98.7K	View

Recent News

PACS Group, Inc. (PACS) Q3 Earnings and Revenues Beat Estimates

Yahoo · 2026-11-03

Lifeward’s ReWalk® Personal Exoskeleton Demonstrates Sustained Long-Term Home Use and Patient Satisfaction in Latest Independent Peer-Reviewed Study

Yahoo · 2026-10-14

Lifeward Announces Publication Of Long-Term Study On User Experience Of Its ReWalk Personal Exoskeleton In 'Spinal Cord Series And Cases'

Benzinga · 2026-10-14

Lifeward Informed By Rami Aviram That He Will Not Assume CFO Role; Josh Hexter To Continue As Interim Principal Financial Officer, Principal Accounting Officer

Benzinga · 2026-10-08

An interim CEO takes on finance duties without extra pay at Lifeward (LFWD).

Stock Titan · 2026-10-01

Peer-Reviewed Study of Lifeward’s ReWalk® Exoskeleton Reports Significant Improvements in Daily Activity Performance, Satisfaction, and Pain

Yahoo Finance · 2026-09-15

Lifeward Publishes Updated Investor Presentation Highlighting Commercial Growth Strategy

Yahoo Finance · 2026-09-08

Lifeward Announces Major CEO and CFO Leadership Changes

The Globe and Mail · 2026-09-01

Lifeward Appoints Josh Hexter Interim Chief Executive Officer and Rami Aviram Chief Financial Officer

Yahoo Finance · 2026-08-31

Lifeward to Report Second Quarter 2026 Financial Results on August 14, 2026

Yahoo Finance · 2026-08-07

Lifeward Launches Pilot Program with Ottobock Care to Expand National Access to ReWalk® Personal Exoskeleton

Yahoo Finance · 2026-08-05

LFWD Forecast — Price Target — Prediction for 2027

TradingView · 2026-06-25

How The Lifeward (LFWD) Story Is Shifting With New Price Targets And Valuation Assumptions

Yahoo Finance · 2026-05-17

Lifeward Ltd (LFWD) Q1 2026 Earnings Call Highlights: Navigating Challenges and Seizing Growth ...

Yahoo Finance · 2026-05-15

Lifeward Ltd. Q1 2026 Earnings Call Summary

Yahoo Finance · 2026-05-15

Informational purposes only, not investment advice.